Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 12-2018 | 06-2018 | 12-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 147 | 113 | 588 | 270 | 727 |
| Other Operating Activity | -4,491 | -2,768 | -4,946 | -2,770 | -5,864 |
| Operating Cash Flow | $-4,344 | $-2,655 | $-4,358 | $-2,500 | $-5,137 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | -2 | -2 | -2 | -137 |
| Other Investing Activity | -339 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-375 | $-2 | $-2 | $-2 | $-137 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,236 | 966 | -8 | -8 | 5,360 |
| Financing Cash Flow | $2,236 | $966 | $-8 | $-8 | $5,360 |
| Exchange Rate Effect | 83 | 77 | 103 | -90 | -230 |
| Beginning Cash Position | 3,924 | 3,934 | 8,519 | 8,440 | 8,428 |
| End Cash Position | 1,525 | 2,319 | 4,254 | 5,830 | 8,284 |
| Net Cash Flow | $-2,400 | $-1,615 | $-4,265 | $-2,610 | $144 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,344 | -2,655 | -4,358 | -2,500 | -5,137 |
| Free Cash Flow | -4,344 | -2,655 | -4,358 | -2,500 | -5,137 |